Phenomapping of subgroups in hypertensive patients using unsupervised data-driven cluster analysis: An exploratory study of the SPRINT trial

12Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Hypertensive patients are highly heterogeneous in cardiovascular prognosis and treatment responses. A better classification system with phenomapping of clinical features would be of greater value to identify patients at higher risk of developing cardiovascular outcomes and direct individual decision-making for antihypertensive treatment. Methods: An unsupervised, data-driven cluster analysis was performed for all baseline variables related to cardiovascular outcomes and treatment responses in subjects from the Systolic Blood Pressure Intervention Trial (SPRINT), in order to identify distinct subgroups with maximal within-group similarities and between-group differences. Cox regression was used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs) for cardiovascular outcomes and compare the effect of intensive antihypertensive treatment in different clusters. Results: Four replicable clusters of patients were identified: cluster 1 (index hypertensives); cluster 2 (chronic kidney disease hypertensives); cluster 3 (obese hypertensives) and cluster 4 (extra risky hypertensives). In terms of prognosis, individuals in cluster 4 had the highest risk of developing primary outcomes. In terms of treatment responses, intensive antihypertensive treatment was shown to be beneficial only in cluster 4 (HR 0.73, 95% CI 0.55–0.98) and cluster 1 (HR 0.54, 95% CI 0.37–0.79) and was associated with an increased risk of severe adverse effects in cluster 2 (HR 1.18, 95% CI 1.05–1.32). Conclusion: Using a data-driven approach, SPRINT subjects can be stratified into four phenotypically distinct subgroups with different profiles on cardiovascular prognoses and responses to intensive antihypertensive treatment. Of note, these results should be taken as hypothesis generating that warrant further validation in future prospective studies.

References Powered by Scopus

2018 ESC/ESH Guidelines for themanagement of arterial hypertension

7750Citations
N/AReaders
Get full text

2016 European Guidelines on cardiovascular disease prevention in clinical practice

5650Citations
N/AReaders
Get full text

A randomized trial of intensive versus standard blood-pressure control

5010Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Artificial intelligence in cardiovascular diseases: diagnostic and therapeutic perspectives

31Citations
N/AReaders
Get full text

Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials

31Citations
N/AReaders
Get full text

Unsupervised hierarchical clustering identifies a metabolically challenged subgroup of hypertensive individuals

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yang, D. Y., Nie, Z. Q., Liao, L. Z., Zhang, S. Z., Zhou, H. M., Sun, X. T., … Liao, X. X. (2019). Phenomapping of subgroups in hypertensive patients using unsupervised data-driven cluster analysis: An exploratory study of the SPRINT trial. European Journal of Preventive Cardiology, 26(16), 1693–1706. https://doi.org/10.1177/2047487319856733

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

72%

Researcher 3

17%

Professor / Associate Prof. 2

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

57%

Engineering 3

21%

Nursing and Health Professions 2

14%

Agricultural and Biological Sciences 1

7%

Save time finding and organizing research with Mendeley

Sign up for free